San Francisco Residents Join Outcry Over EpiPen Costs With Class Action Lawsuit
The lawsuit alleges that Mylan’s “unfair and oppressive pricing” leaves thousands of California children and adults in danger of dying because they cannot afford the drug.
The Mercury News:
EpiPen Manufacturer Target Of Class Action Lawsuit Filed In Bay Area
Already under investigation by two federal agencies, the pharmaceutical company at the center of the EpiPen controversy is facing another Northern California-based class-action lawsuit over allegations of price gouging. The complaint against Mylan, filed in U.S. District Court in San Francisco last week on behalf of San Francisco resident Robin Kozelka and others affected, said the case arises out of “one of the most shocking and cruelest examples of corporate greed in recent memory.” (Seipel, 11/15)